on-Hodgkins lymphoma T-cell protocol

Completed

• Conditions: ymphoma (non-Hodgkins); Cancer; Lymphoma (non-Hodgkins)

• Registration Number: ISRCTN73274643
• Lead Sponsor: Cancer Research UK (CRUK) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2001-07-01
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. T-cell non-Hodgkin's lymphoma
2. Stages I-IV
3. Confirmed remission achieved
4. Less than 25% blasts in bone marrow
5. No circulating blasts in blood
6. Aged <18 years

Exclusion Criteria

Patients with T-cell anaplastic lymphoma or peripheral T-cell lymphoma are excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ot provided at time of registration

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration